BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2021
View Archived Issues
Dosing begins in phase II trial of CGB-400 for rosacea
Read More
Dr. Reddy's licenses anti-BCMA CAR T PRG-1801 for India
Read More
Sumitomo Dainippon Pharma to study DSP-0038 in phase I for Alzheimer's disease psychosis
Read More
New METTL3 inhibitors identified at Accent Therapeutics
Read More
Merck & Co. divulges new LRRK2 inhibitors
Read More
New hepatitis C virus NS5A protein inhibitors discovered at Alla Chem
Read More
Alphala patents anticancer compounds
Read More
Sunshine Lake Pharma describes new mineralocorticoid receptor antagonists
Read More
Lentiviral gene transfer used to develop model of TGF-beta-2-induced ocular hypertension
Read More
Protein kinase analysis identifies potential therapeutic targets for Friedreich's ataxia
Read More
H. pylori oncoprotein-induced genome instability may underlie gastric cancer
Read More
Dosing initiates in phase I study of GFB-024 in severe insulin-resistant diabetic nephropathy
Read More
ReGenTree reports further phase III data on RGN-259 for dry eye syndrome
Read More
FDA approves Zynrelef for postsurgical analgesia
Read More
Stem cell lentiviral therapy restores neuromuscular symptoms in models of Pompe disease
Read More
Enrollment opens in phase I/II study of BLU-945 in patients with EGFR mutant NSCLC
Read More
TG Therapeutics initiates phase Ib study of TG-1801 in B-cell lymphoma or CLL
Read More
Preliminary clinical data of highly purified chimeric antigen receptor T-cell therapy targeting CD19
Read More
Astellas studies ASP-0367 in phase II/III for primary mitochondrial myopathy
Read More
R0.6C vaccine candidate for malaria enters first-in-human study
Read More
Phase Ib/IIa trial evaluates tigilanol tiglate with pembrolizumab in advanced melanoma
Read More